Featured News
Articles, videos, and features highlighting the work of Center investigators
– The AtlanticWill Omicron Leave Most of Us Immune?
The variant is spreading widely, but won’t necessarily give us strong protection from new infections.
– News CenterAllergies to mRNA-based COVID-19 vaccines rare, generally mild, Stanford-led study finds
In a study of mRNA-based COVID-19 vaccine doses given at Stanford Medicine, vaccine allergies were rare, mild and mostly triggered by a vaccine additive, not the mRNA.
– The AtlanticOmicron Has Created a Whole New Booster Logic
For a while I was on the fence about getting another shot. Then came the newest variant of concern.
– SciTechDailyMilder COVID-19 Symptoms Tied to Prior Run-Ins With Other (Common Cold) Coronaviruses
In COVID-19 patients whose symptoms were mild, Stanford researchers found that they were more likely than sicker patients to have signs of prior infection by similar, less virulent coronaviruses. A study by Stanford University School of Medicine investigators hints that people with COVID-19 may e
– News CenterStudy shows why second dose of COVID-19 vaccine shouldn’t be skipped
Scientists scrutinized Pfizer vaccine recipients’ blood samples to learn exactly what effects the vaccine exerts on the body’s immune system.